of the Company. For the six-month period Ended June 30, 2019, which was audited by the auditor with significant operational results as follows: 1. Net profit in the amount of 21.92 million baht

tangible assets by calculating from the audited consolidated financial statement of the Company and its subsidiaries as at March 31st, 2018. Size of Transaction = Value of Transaction / Net Tangible Assets

audited consolidated financial statement of the Company and its subsidiaries as at September 30th, 2019 Size of Transaction = Value of Transaction / Net Tangible Assets = THB 96,6000,000.00 / THB

based on a total value of consideration paid basis, calculated from the audited consolidated financial statements of the Company for the year ended 31 December 2017. In the previous 6- month period, the

of consideration based on the Company’s consolidated financial statements as of 31 December 2019 audited by the certified auditor. There is no acquisition transaction to be incurred in the past 6

Company’s Debt to Equity ratio is 1.48 times, based on the audited consolidated financial statements for the 9-month period ended September 30, 2019. The Debt to Equity ratio will rise to 1.26 times if the

208,211.87 Source: Financial Statements of 2016 which was audited by the Auditor Financial in the notes to the financial statements that Anypay has increased its registered capital to Baht 5.00 million divided

Company’s Audited Financial Statements for the year 2018 ended 31 December 2018, which has been audited by the auditor, and propose to the Annual General Meeting of Shareholders (“AGM”) to consider and

Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book

financial statement ended on December 31, 2019 which has been audited by the auditor and reviewed by the Audit Committee. The board has also endorsed the statements. 3. Approved to propose the Shareholders